4//SEC Filing
CAVANAUGH JAMES H 4
Accession 0001104659-24-119795
CIK 0001509745other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:31 PM ET
Size
8.5 KB
Accession
0001104659-24-119795
Insider Transaction Report
Form 4
CAVANAUGH JAMES H
Director
Transactions
- Exercise of In-Money
Common Stock
2024-11-13$2.82/sh+213$601→ 213 total - Exercise of In-Money
Warrant (Right to Buy)
2024-11-13−213→ 0 totalExercise: $2.82From: 2017-11-14Exp: 2024-11-14→ Common Stock, $0.001 par value per share (213 underlying)
Holdings
- 261,840(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]On November 13, 2024, James Cavanaugh exercised a warrant to purchase 213 shares of the Issuer's common stock at an exercise price of $2.82 per share.
- [F2]These shares are held by the HCV VIII Trust (the "HCV Trust"). The reporting person is a beneficiary of the HCV Trust and may be deemed to have beneficial ownership of the 261,840 shares of Common Stock held by the HCV Trust. The reporting person disclaims beneficial ownership of such shares of Common Stock held by the HCV Trust, except to the extent of the reporting person's proportionate pecuniary interest in such shares of Common Stock.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001013473
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:31 PM ET
- Size
- 8.5 KB